Tissue manufacturing at scale. Unlock commercially viable scale with automated manufacturing.
Therapies are failing at scale, not in the clinic. The bottleneck is manual production.
Mytos’ automated facilities enables scaling to thousands of patients in months not years at lower costs than manual.
4×
Faster
Scaling
10×
Batches
Per Cleanroom
40%
Lower Cost
Per batch
10×
Fewer
FTE hours
Leading teams scale with Mytos.
“The Mytos iDEM system, together with our bioinformatics and other enabling technologies, allows us to scale out for Phase 3 and ultimately commercialization, making more product at lower cost.”
Kim Raineri CTO · Aspen Neuroscience Manufacture with Mytos.
